Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Parenthetical)

v2.4.0.6
Consolidated Statements of Stockholders' Equity (Parenthetical) (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Issuance of common stock in private placement to related party     $ 1.00
Issuance of common stock in private placement, including related parties     $ 1.00
Issuance of Series D preferred stock     8.00%
Purchase of shares $ 3.27   $ 3.55
Issuance of common stock, per share $ 3.75    
Issuance of common stock for acquisition   $ 1.46  
Common Stock
     
Issuance of common stock in private placement to related party     $ 1.00
Issuance of common stock in private placement, including related parties     $ 1.00
Issuance of common stock, per share $ 3.75    
Treasury Stock
     
Purchase of shares $ 3.27   $ 3.55
Additional Paid-in Capital
     
Issuance of common stock in private placement to related party     $ 1.00
Issuance of common stock in private placement, including related parties     $ 1.00
Issuance of Series D preferred stock     8.00%
Issuance of common stock, per share $ 3.75    
Pharmacos Exakta | Common Stock
     
Issuance of common stock for acquisition   $ 1.46  
Pharmacos Exakta | Additional Paid-in Capital
     
Issuance of common stock for acquisition   $ 1.46  
Claros
     
Issuance of common stock for acquisition $ 5.04    
Claros | Common Stock
     
Issuance of common stock for acquisition $ 5.04    
Claros | Treasury Stock
     
Issuance of common stock for acquisition $ 5.04    
Claros | Additional Paid-in Capital
     
Issuance of common stock for acquisition $ 5.04    
FineTech
     
Issuance of common stock for acquisition $ 4.90    
FineTech | Common Stock
     
Issuance of common stock for acquisition $ 4.90    
FineTech | Additional Paid-in Capital
     
Issuance of common stock for acquisition $ 4.90